Krystal Biotech, Inc. (KRYS) Operating cash flow 2016–2025
Krystal Biotech, Inc. (KRYS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$200.9MFY2025 · since FY2016: -$1.3M → $200.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $200.9M | +62.7% |
| FY2024 | $123.4M | +239.0% |
| FY2023 | -$88.8M | +11.7% |
| FY2022 | -$100.6M | -109.8% |
| FY2021 | -$47.9M | -83.8% |
| FY2020 | -$26.1M | -39.6% |
| FY2019 | -$18.7M | -97.9% |
| FY2018 | -$9.4M | -142.8% |
| FY2017 | -$3.9M | -196.7% |
| FY2016 | -$1.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KRYS financial trends
KRYS RevenueKRYS Net incomeKRYS Net marginKRYS Gross profitKRYS Gross marginKRYS Operating incomeKRYS Operating marginKRYS Free cash flowKRYS Capital expendituresKRYS Return on equityKRYS Stock buybacksKRYS Dividends paidKRYS Total assetsKRYS Total liabilitiesKRYS Shareholders’ equityKRYS overview →